South Korea’s box office staged a sharp recovery during the first half of 2026, with revenue climbing 41.9% year-on-year to KRW 579 billion (USD $397 million) and admissions rising 34.2% to 57 million. The turnaround follows a dismal first half of 2025, when attendance fell to roughly 42 million, the market’s weakest non-pandemic performance in more than two decades. Korean moviegoers, it turns out, had not permanently left the building; they needed a slate worth returning for.

Local films powered the rebound, generating KRW 370.2 billion (USD $254 million), an 81.7% increase, from 37.37 million admissions. Korean titles captured 63.9% of box office revenue, recovering to 94.2% of the average recorded during the first halves of 2017 through 2019. Jang Hang-jun’s period drama “The King’s Warden” led the market with KRW 163.1 billion (USD $111.7 million) and 16.9 million admissions, becoming the highest-grossing Korean film of all time. “Colony” followed with KRW 60.5 billion, while low-budget horror “Salmokji: Whispering Water” earned KRW 33.3 billion. Showbox distributed all three and finished the half with a commanding 48.6% revenue share; an extraordinary result, albeit one that also shows how concentrated the recovery was around a handful of breakout releases.

Imports offered exhibitors a different kind of win. Foreign-film revenue edged up 2.3% to KRW 208.8 billion (USD $146 million) even as admissions declined 6.9% to 19.68 million. “Project Hail Mary” was the leading import with KRW 33 billion (USD $23.1 million), while revenue from IMAX, 4D, ScreenX, Dolby Cinema and other premium formats jumped 56.3% to KRW 45.7 billion (USD $32 billion). For exhibitors, that may be the more durable takeaway: Korean blockbusters restored audience volume, while premium formats helped extract more value from Hollywood releases attracting fewer patrons.